BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16212005)

  • 1. [Alcoholic and nonalcoholic steatohepatitis: the same disease! II. Management].
    Spahr L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2032-4. PubMed ID: 16212005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Alcoholic and nonalcoholic steatohepatitis: the same disease! I. Diagnosis and mechanisms].
    Spahr L; Rubbia-Brandt L; Hadengue A
    Rev Med Suisse; 2005 Sep; 1(31):2026-8, 2030-1. PubMed ID: 16212004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic steatohepatitis and metabolic syndrome.
    Machado M; Cortez-Pinto H
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):637-42. PubMed ID: 16912563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non alcoholic steatohepatitis: an emergent and potentially serious pathology].
    Elloumi H; Arfaoui D; Joudène M; Sriha B; Korbi M; Ajmi S
    Tunis Med; 2004 Jun; 82(6):484-91. PubMed ID: 15517946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis.
    Younossi ZM
    Aliment Pharmacol Ther; 2008 Jul; 28(1):2-12. PubMed ID: 18410557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.
    Barshop NJ; Sirlin CB; Schwimmer JB; Lavine JE
    Aliment Pharmacol Ther; 2008 Jul; 28(1):13-24. PubMed ID: 18397387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonalcoholic fatty liver disease.
    Angulo P
    Rev Gastroenterol Mex; 2005 Nov; 70 Suppl 3():52-6. PubMed ID: 17471859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment strategies in nonalcoholic fatty liver disease.
    Tilg H; Kaser A
    Nat Clin Pract Gastroenterol Hepatol; 2005 Mar; 2(3):148-55. PubMed ID: 16265156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of non-alcoholic steatohepatitis.
    McClain CJ; Mokshagundam SP; Barve SS; Song Z; Hill DB; Chen T; Deaciuc I
    Alcohol; 2004 Aug; 34(1):67-79. PubMed ID: 15670668
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Therapeuric aspects of NAFLD. A literature review].
    Tapia NC; Avila FI; Leiva JG; Ramos MH; Avila JF; Uribe M
    Rev Gastroenterol Mex; 2006; 71(4):487-95. PubMed ID: 17542283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on non-alcoholic fatty liver disease in children.
    Papandreou D; Rousso I; Mavromichalis I
    Clin Nutr; 2007 Aug; 26(4):409-15. PubMed ID: 17449148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Review article: Drug therapy for non-alcoholic fatty liver disease.
    Comar KM; Sterling RK
    Aliment Pharmacol Ther; 2006 Jan; 23(2):207-15. PubMed ID: 16393299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Medical treatment of non-alcoholic steatohepatitis.
    Kadayifci A; Merriman RB; Bass NM
    Clin Liver Dis; 2007 Feb; 11(1):119-40, ix. PubMed ID: 17544975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Obesity and non-alcoholic steatohepatitis].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Gac Med Mex; 2004; 140 Suppl 2():S67-72. PubMed ID: 15641474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic syndrome is associated with severe fibrosis in chronic viral hepatitis and non-alcoholic steatohepatitis.
    Tsochatzis E; Papatheodoridis GV; Manesis EK; Kafiri G; Tiniakos DG; Archimandritis AJ
    Aliment Pharmacol Ther; 2008 Jan; 27(1):80-9. PubMed ID: 17919273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of patients with non-alcoholic fatty liver disease: current views and perspectives.
    Federico A; Trappoliere M; Loguercio C
    Dig Liver Dis; 2006 Nov; 38(11):789-801. PubMed ID: 16750661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Non-alcoholic fatty liver disease--new view].
    Raszeja-Wyszomirska J; Lawniczak M; Marlicz W; Miezyńska-Kurtycz J; Milkiewicz P
    Pol Merkur Lekarski; 2008 Jun; 24(144):568-71. PubMed ID: 18702346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic strategies in nonalcoholic fatty liver disorders.
    Poordad FF
    Expert Opin Emerg Drugs; 2005 May; 10(2):237-9. PubMed ID: 15934865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of weight loss on nonalcoholic fatty liver disease.
    Rafiq N; Younossi ZM
    Semin Liver Dis; 2008 Nov; 28(4):427-33. PubMed ID: 18956298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [An update on non-alcoholic fatty liver disease].
    Méndez-Sánchez N; Chávez-Tapia NC; Uribe M
    Rev Invest Clin; 2004; 56(1):72-82. PubMed ID: 15144045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.